Back
InMed Pharmaceuticals Stock Price Chart

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
54
INM
InMed Pharmaceuticals
Last Price:
$2.95
Seasonality Move:
-19.46%
7 Day Trial
ALL ACCESS PASS
$
7

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and INM is experiencing slight buying pressure.
InMed Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.7 | Buy |
20-day SMA: | 2.84 | Buy |
50-day SMA: | 2.66 | Buy |
200-day SMA: | 4.09 | Sell |
8-day EMA: | 2.77 | Buy |
20-day EMA: | 2.76 | Buy |
50-day EMA: | 2.83 | Buy |
200-day EMA: | 4.84 | Sell |
InMed Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 63.89 | Buy |
Chaikin Money Flow: | 225821 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.53 - 3.07) | Buy |
Bollinger Bands (100): | (2.42 - 4.06) | Buy |
InMed Pharmaceuticals Technical Analysis
May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for InMed Pharmaceuticals Stock
Is InMed Pharmaceuticals Stock a Buy?
-
InMed Pharmaceuticals share price is 3.36 while INM 8-day simple moving average is 2.70, which is a Buy signal.
-
The stock price of INM is 3.36 while InMed Pharmaceuticals 20-day SMA is 2.84, which makes it a Buy.
-
InMed Pharmaceuticals 50-day simple moving average is 2.66 while INM share price is 3.36, making it a Buy technically.
-
INM stock price is 3.36 and InMed Pharmaceuticals 200-day simple moving average is 4.09, creating a Sell signal.
INM Technical Analysis vs Fundamental Analysis
Buy
54
InMed Pharmaceuticals (INM)
is a Buy
Is InMed Pharmaceuticals a Buy or a Sell?
-
InMed Pharmaceuticals stock is rated a BuyThe current InMed Pharmaceuticals [INM] share price is $3.36. The Score for INM is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
InMed Pharmaceuticals Stock Info
Market Cap:
4.1M
Price in USD:
3.36
Share Volume:
3.1M
InMed Pharmaceuticals 52-Week Range
52-Week High:
15.70
52-Week Low:
1.72
Buy
54
InMed Pharmaceuticals (INM)
is a Buy
InMed Pharmaceuticals Share Price Forecast
-
What is the InMed Pharmaceuticals stock price today?The InMed Pharmaceuticals stock price is 3.36 USD today.
-
Will INM stock go up or go down?InMed Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is InMed Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, InMed Pharmaceuticals is not overvalued.
Is InMed Pharmaceuticals Stock a Buy?
-
InMed Pharmaceuticals share price is 3.36 while INM 8-day exponential moving average is 2.77, which is a Buy signal.
-
The stock price of INM is 3.36 while InMed Pharmaceuticals 20-day EMA is 2.76, which makes it a Buy.
-
InMed Pharmaceuticals 50-day exponential moving average is 2.83 while INM share price is 3.36, making it a Buy technically.
-
INM stock price is 3.36 and InMed Pharmaceuticals 200-day simple moving average is 4.84, creating a Sell signal.
Technical Analysis of InMed Pharmaceuticals
Should I short InMed Pharmaceuticals stock?
-
INM Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting InMed Pharmaceuticals is a Buy
-
InMed Pharmaceuticals Relative Strength Index (RSI) is 63.89, which suggest InMed Pharmaceuticals is overbought
-
The Bollinger Bands (25) for InMed Pharmaceuticals is (2.53 - 3.07), which suggest InMed Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for InMed Pharmaceuticals is (2.42 - 4.06), which suggest InMed Pharmaceuticals is a Buy
* InMed Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.